Project Grant CDS9924G0013

Award Date 8/1/24
Completion Date 7/31/25
Dollars Obligated $230K
Federal Grant Program
95.010
Assistance Type
Project Grant
Place of Performance
Mississippi, USA
Similar Awards
This Project Grant award of $5,114,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493) aims to expand and enhance mental and behavioral health services at Mississippi State University (MSU). The key products and services to be delivered through this funding include: Establishing a new mental and behavioral health clinic at MSU's Meridian campus, which will involve renovating dedicated clinic space, hiring a...
The Mississippi State University (MSU) was awarded a $350,000 Project Grant under the Congressional Directives program (CFDA 95.010) by the Executive Office of the President's Office of the National Drug Control Policy. The grant aims to establish a Collegiate Recovery Program (CRP) at MSU to support students in recovery from substance use disorders. Key activities include: Information dissemination through public service announcements, brochures, digital signage, and posters across campus and...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $259,391 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Washington County in Greenville, Mississippi. The grant will fund the "Health Equity and Improvements Gained through Holistic Treatment (H.E.I.G.H.T)" project, which aims to expand intervention court services for court-involved Black/African American adults...
The U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $303,189 Project Grant (CFDA 93.243) to Illinois College to implement the "EMPOWER YOUR LIFE - THE CHESLEY PATH TO WELL-BEING (EMPOWER)" program. The 3-year grant, effective September 30, 2024, aims to address mental health and substance use disorders among the college's 886 students. Key program activities include: Establishing a Behavioral Health Coalition to...
This $3,805,083 federal Project Grant award was made by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The award will establish the Center for Behavioral Health Screening, Outreach, Assessment, and Resilience (CBH-SOAR) clinic at the University of Southern Mississippi to provide services for adolescents and young adults at clinical high risk for...
This $390,596 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) aims to reduce recidivism, morbidity, and mortality related to substance use disorders (SUDs) and co-occurring mental health disorders in a high-need, low-resource adult felony drug court in Mississippi. The key products and services to be delivered include: Providing...
This $4,000,000 Project Grant was awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (CFDA 93.104) federal grant program. The grant recipient, Hinds County Mental Health Commission doing business as Hinds Behavioral, will use the funding to expand the NFUSION Metro System of Care to improve mental health outcomes for children, youth, and young adults up to...
This is a $1,555,700 cooperative agreement awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The award will fund the Morehouse School of Medicine (MSM) to provide evidence-based training, technical assistance, and resources to behavioral health and primary care providers serving individuals with substance use disorders in the southeastern...
This federal Project Grant award, in the amount of $201,492, was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant will enable Widener University to strengthen its infrastructure and deliver a comprehensive suicide prevention program for its 3,166 full-time undergraduate and graduate students on its Chester, PA campus. Key...
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA) Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, awarded a $28,398,148 project grant to the Mississippi Department of Mental Health. The grant, with a performance period from September 30, 2024 to September 29, 2027, will support the implementation of the state's Opioid and Stimulant Use Disorder...

The Project Grant award of $230,000.00 from the Executive Office of the President's Office of the National Drug Control Policy under the Congressional Directives program (CFDA 95.010) will enable Hinds Community College, a minority-serving institution in Mississippi, to expand access to mental health services and implement a college-wide substance abuse prevention program. Key services to be provided include:

  • Adding two counselors to offer free and confidential counseling to students and employees struggling with substance use, including therapeutic and peer support groups
  • Providing educational talks in classrooms and facilitating prevention events to increase awareness of substance abuse and mental health issues
  • Partnering with external agencies to offer more intensive treatment options when needed

The project aims to address challenges faced by Hinds' students, many of whom come from low-income or rural backgrounds with limited access to quality healthcare. The award has a performance period from August 1, 2024 to July 31, 2025.

Generated 5/13/25, 3:24 AM